LXRX

NASDAQStock

Lexicon Pharmaceuticals, Inc.

$1.69-0.04 (-2.03%)

52-Week Range

$0.33

$1.76

Key Stats

Market Cap

704.1M

P/E Ratio

—

Dividend Yield

—

Beta

1.01

Volume

1.9M

Avg Volume

2.8M

Performance

+31.30%

+39.84%

+53.57%

YTD

+50.88%

+369.30%

-24.89%

-74.96%

Price Chart

ETF Exposure

LXRX is held by 13 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
QQQS	Invesco NASDAQ Future Gen 200 ETF	0.58%	46,275	$80K	$13.4M	0.20%
VFLQ	Vanguard U.S. Liquidity Factor ETF	0.52%	13,773	$33K	$38.3M	0.13%
PRFZ	Invesco RAFI US 1500 Small-Mid ETF	0.04%	559,054	$962K	$2.67B	0.34%
SCHA	Schwab U.S. Small-Cap ETF	0.01%	920,800	$1.5M	$19.55B	0.04%
VHT	Vanguard Health Care ETF	0.00%	551,784	$640K	$19.80B	0.09%
VXF	Vanguard Extended Market ETF	0.00%	1,979,562	$2.3M	$84.10B	0.05%
SCHB	Schwab U.S. Broad Market ETF	0.00%	108,714	$184K	$37.50B	0.03%
VCNS.TO	Vanguard Conservative ETF Portfolio	0.00%	337	$529	$820.6M	0.25%
VEQT.TO	Vanguard All-Equity ETF Portfolio	0.00%	12,027	$19K	$12.17B	0.24%
VRIF.TO	Vanguard Retirement Income ETF Portfolio	0.00%	58	$91	$337.7M	0.32%
VTI	Vanguard Total Stock Market ETF	0.00%	6,847,451	$7.9M	$2.10T	0.03%
VUN.TO	Vanguard U.S. Total Market Index ETF	0.00%	36,016	$57K	$15.33B	0.17%
VUS.TO	Vanguard U.S. Total Market Index ETF (CAD-hedged)	0.00%	3,105	$5K	$1.29B	0.17%

About LXRX ETF Exposure

Lexicon Pharmaceuticals, Inc. (LXRX) is held by 13 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 704.1M, LXRX is a widely held institutional stock. The stock currently trades at $1.69. Investors can gain exposure to LXRX through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold LXRX, sorted by portfolio weight.